OCS - Oculis Holding AG

QQQ $ 458.17 $ 1.81 (0.4 %)

DIA $ 408.04 $ -1.57 (-0.38 %)

SPY $ 548.38 $ -0.01 (-0 %)

TLT $ 100.64 $ 0.73 (0.73 %)

GLD $ 232.41 $ 0.00 (0 %)

Previous Close

$ 11.955

Open

$ 12.00

Bid

$ 12.10 x 101

Ask

$ 12.15 x 100

Day's Range

$ 12.00 - $ 12.15

52 Week Range

$ 9.05 - $ 14.47

Volume

5,459

Average Volume

Market Cap

196.04M

Beta (5Y Monthly)

$ 0.57

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Ocul...
08/28/2024 10:25:27

HC Wainwright & Co. analyst Yi Chen reiterates Oculis Holding (NASDAQ:OCS) with a Buy and maintains $30 price target.

Oculis Holding Q2 2024 Adj. EPS CHF(0.51) ...
08/27/2024 08:03:23

autonation-baxter-international-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

AutoNation, Baxter International And Other...
07/15/2024 12:14:29

Chardan Capital Reiterates Buy on Oculis H...
06/11/2024 14:37:11

Chardan Capital analyst Daniil Gataulin reiterates Oculis Holding (NASDAQ:OCS) with a Buy and maintains $30 price target.

alphabet-to-rally-over-28-here-are-10-top-analyst-forecasts-for-tuesday

Alphabet To Rally Over 28%? Here Are 10 To...
06/11/2024 12:53:07

B of A Securities Maintains Buy on Oculis ...
06/11/2024 11:19:58

B of A Securities analyst Jason Gerberry maintains Oculis Holding (NASDAQ:OCS) with a Buy and lowers the price target from $...

HC Wainwright & Co. Maintains Buy on Oculi...
06/11/2024 11:01:50

HC Wainwright & Co. analyst Yi Chen maintains Oculis Holding (NASDAQ:OCS) with a Buy and raises the price target from $2...

Baird Maintains Outperform on Oculis Holdi...
06/11/2024 10:46:05

Baird analyst Colleen Kusy maintains Oculis Holding (NASDAQ:OCS) with a Outperform and raises the price target from $35 to $37.

Oculis Announces Topline Results From Its ...
06/10/2024 09:13:22

Improvements in multiple sign efficacy endpoints were observed in full population and with predictive and more pronounced eff...

HC Wainwright & Co. Reiterates Buy on Ocul...
05/30/2024 10:28:59

HC Wainwright & Co. analyst Yi Chen reiterates Oculis Holding (NASDAQ:OCS) with a Buy and maintains $28 price target.

HC Wainwright & Co. Reiterates Buy on Ocul...
05/13/2024 11:15:22

HC Wainwright & Co. analyst Yi Chen reiterates Oculis Holding (NASDAQ:OCS) with a Buy and maintains $28 price target.

Oculis Holding Q1 EPS $(0.50) Misses $(0.4...
05/08/2024 23:12:58

Oculis Holding (NASDAQ:OCS) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.4...

Oculis Announces Completion Of Enrollment ...
05/08/2024 21:46:02

Topline results anticipated in Q4 2024 for Phase 2 trial evaluating the safety and tolerability of OCS-05 in patients with Acut...

HC Wainwright & Co. Maintains Buy on Oculi...
04/24/2024 10:27:36

HC Wainwright & Co. analyst Yi Chen maintains Oculis Holding (NASDAQ:OCS) with a Buy and lowers the price target from $2...

Chardan Capital Maintains Buy on Oculis Ho...
03/19/2024 13:09:14

Chardan Capital analyst Daniil Gataulin maintains Oculis Holding (NASDAQ:OCS) with a Buy and maintains $30 price target.

Baird Maintains Outperform on Oculis Holdi...
03/19/2024 11:16:21

Baird analyst Colleen Kusy maintains Oculis Holding (NASDAQ:OCS) with a Outperform and lowers the price target from $64 to $35.

Oculis's 2023 Cash, Cash Equivalents, And ...
03/18/2024 10:39:23

Oculis Holding Q4 GAAP EPS CHF(0.34) Up Fr...
03/18/2024 10:37:33

Wedbush Reiterates Outperform on Oculis Ho...
03/06/2024 16:09:24

Wedbush analyst Andreas Argyrides reiterates Oculis Holding (NASDAQ:OCS) with a Outperform and maintains $29 price target.

HC Wainwright & Co. Reiterates Buy on Ocul...
02/29/2024 14:04:21

HC Wainwright & Co. analyst Yi Chen reiterates Oculis Holding (NASDAQ:OCS) with a Buy and maintains $29 price target.